United States · Health Care · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
58.67%
2025 (actual)
ROA
-236.57%
2025 (actual)
Gross Margin
74.45%
2025 (actual)
Net Margin
-416.69%
2025 (actual)
Total Assets
$1,324.00K
2025 (actual)
Net Income
-$3,196.00K
2025 (actual)
Valuation
$52,130.17K
2025 (actual)
Stock Price
$0.54
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
-32.6 pt
Company
Sector average
ROA
-482.4 pt
Company
Gross Margin
-16.3 pt
Company
Sector average
Net Margin
-121.9 pt
Company
Total Assets
-16.8%
Company
Net Income
-140.2%
Company
Valuation
+140.2%
Company
Stock Price
+140.7%
Company
USD|Thousands
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for GUIDED THERAPEUTICS INC? It covers the balance sheet, income statement, cash flow and Equlion model projections.